UK Sepsis Diagnostics Market Size & Outlook, 2022-2030
UK sepsis diagnostics market, 2018-2030 (US$M)
Related Markets
UK sepsis diagnostics market highlights
- The UK sepsis diagnostics market generated a revenue of USD 45.1 million in 2022 and is expected to reach USD 82.5 million by 2030.
- The UK market is expected to grow at a CAGR of 7.8% from 2023 to 2030.
- In terms of segment, blood culture media was the largest revenue generating product in 2022.
- Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
| Market revenue in 2022 | USD 45.1 million |
| Market revenue in 2030 | USD 82.5 million |
| Growth rate | 7.8% (CAGR from 2022 to 2030) |
| Largest segment | Blood culture media |
| Fastest growing segment | Assay Kits & Reagents |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, UK accounted for 4.5% of the global sepsis diagnostics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 82.5 million by 2030.
Blood culture media was the largest segment with a revenue share of 39.02% in 2022. Horizon Databook has segmented the UK sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
According to the UK Sepsis Trust, sepsis claims a life every three seconds worldwide. In the UK alone, approximately 245,000 people are affected by sepsis each year, with around 48,000 succumbing to sepsis-related illnesses annually.
This figure exceeds the combined death rates of breast, bowel, and prostate cancers. On a global scale, sepsis is responsible for about 11 million deaths annually. Despite its severity, early diagnosis can make sepsis highly treatable in many cases.
The UK Sepsis Trust (UKST) is dedicated to combating this life-threatening condition by preventing avoidable deaths and providing support for those impacted by sepsis. The Trust works to improve awareness, advance early diagnosis, and enhance treatment protocols.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK sepsis diagnostics market size, by product, 2018-2030 (US$M)
UK Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
